WEST Innovation Series: The New CEO–Always Learning and Setting the Tone for Innovation on Day One

Download IconDownload Print IconPrint

WEST Innovation Series: The New CEO–Always Learning and Setting the Tone for Innovation on Day One

Cambridge, MA
Speaking Engagement
This event is part of Women Entrepreneurs in Science & Technology’s (WEST) inaugural Innovation Series that is comprised of panel discussions with biotech and technology industry’s most successful entrepreneurs and innovators on how they have created, nurtured, and inspired “Innovation Throughout the Company’s Life Cycle.” Panelists will discuss their first-hand experience in developing employee careers and advancing more talented women into senior positions.

The CEO panel will discuss what motivated them to be CEOs, share early leadership lessons, competencies for success as well their experiences in building startup companies. They will also discuss their leadership styles and how they build and develop their teams.

Panelists include Amy Schulman, CEO, Arsia Therapeutics; Katrine Bosley, CEO, Editas Medicine and Nancy Simonian, CEO, Syros Pharmaceuticals.

Read More About the Event

You May Be Interested In

AIPLA Claim Construction Webinar

April 25, 2024
Speaking Engagement

PLI's Corporate Governance – A Master Class 2024

April 25, 2024
Speaking Engagement

FIA Law & Compliance Division Conference 2024

April 24–26, 2024
Speaking Engagement
View all Events

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel